FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
ATARA Biotherapeutics (NASDAQ: ATRA) reported Q4 EPS of ($0.96), $0.27 worse than the analyst estimate of ($0.69).
For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.
... More
